Peel Hunt restated their hold rating on shares of Abcam (LON:ABC) in a research report sent to investors on Wednesday. The firm currently has a GBX 1,020 ($13.66) price target on the stock.
A number of other equities analysts also recently issued reports on ABC. Panmure Gordon reissued a sell rating on shares of Abcam in a research note on Monday, September 11th. Berenberg Bank reissued a buy rating and issued a GBX 1,100 ($14.73) price target on shares of Abcam in a research note on Monday, September 11th. J P Morgan Chase & Co reissued a neutral rating and issued a GBX 864 ($11.57) price target on shares of Abcam in a research note on Tuesday, September 12th. Finally, Numis Securities increased their price target on shares of Abcam from GBX 1,116 ($14.95) to GBX 1,200 ($16.07) and gave the stock an add rating in a research note on Tuesday, September 12th. One research analyst has rated the stock with a sell rating, four have given a hold rating and one has given a buy rating to the company’s stock. Abcam currently has a consensus rating of Hold and a consensus target price of GBX 972.67 ($13.03).
Shares of Abcam (LON ABC) opened at GBX 984.75 ($13.19) on Wednesday. Abcam has a 1-year low of GBX 9.73 ($0.13) and a 1-year high of GBX 1,113 ($14.91).
The firm also recently announced a dividend, which will be paid on Friday, December 8th. Shareholders of record on Thursday, November 16th will be paid a dividend of GBX 7.36 ($0.10) per share. This is an increase from Abcam’s previous dividend of $2.83. The ex-dividend date of this dividend is Thursday, November 16th. This represents a dividend yield of 0.71%.
In other news, insider Louise Patten purchased 1,636 shares of Abcam stock in a transaction that occurred on Thursday, September 14th. The stock was bought at an average price of GBX 1,079 ($14.45) per share, with a total value of £17,652.44 ($23,640.61). Also, insider Jonathan Simon Milner sold 567,033 shares of the firm’s stock in a transaction that occurred on Thursday, September 21st. The shares were sold at an average price of GBX 1,017 ($13.62), for a total transaction of £5,766,725.61 ($7,722,948.45).
COPYRIGHT VIOLATION NOTICE: This article was first posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this article on another publication, it was copied illegally and reposted in violation of US & international trademark & copyright legislation. The original version of this article can be viewed at https://www.dispatchtribunal.com/2017/11/30/abcam-abc-receives-hold-rating-from-peel-hunt.html.
Abcam Company Profile
Abcam plc is a global life sciences company. As a developer of reagents and tools, the Company’s purpose is to serve life science researchers globally. Providing the research and clinical communities with tools and scientific support, the Company offers validated biological binders and assays to address important targets in critical biological pathways.
Receive News & Ratings for Abcam Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abcam Plc and related companies with MarketBeat.com's FREE daily email newsletter.